The good, the bad and the downright ugly of the year in biotech and health.
News
- Theranos' Elizabeth Holmes, Zymergen and Covid make 2021's top biotech-health stories
- Paychex, Tesla rise; CalAmp, Allakos fall - San Antonio Express-News
Investors were disappointed with the biotechnology company's latest update on its drug development program. CalAmp Corp., down $2.55 to $7.34.
- Paychex, Tesla rise; CalAmp, Allakos fall - mySA
San Antonio's second Ojos Locos to open at South Park Mall ... Investors were disappointed with the biotechnology company's latest update on its ...
- Pfizer pill becomes 1st US-authorized home COVID treatment - KENS 5
San Antonio, TX ». 65°. San Antonio, TX » ... For more than a year, biotech-engineered antibody drugs have been the go-to treatments for COVID-19.
- University of San Antonio Earns Top Research Designation - Government Technology
With projects in cybersecurity, AI, extreme environments, biomedical breakthroughs and educational disparities, the 2021 Carnegie classifications ...